Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice
- PMID: 17145894
- DOI: 10.1158/0008-5472.CAN-06-1969
Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice
Abstract
Adiponectin is an adipokine that has pleiotropic beneficial roles in systemic insulin resistance and inflammation. Several recent clinical studies suggest that low serum levels of adiponectin are associated with increased risks of breast cancer. Here, we investigated the direct effects of adiponectin on breast cancer development in vitro and in vivo. Our results showed that adiponectin significantly attenuated the proliferations of two typical human breast cancer cells, MDA-MB-231 and T47D, in a cell type-specific manner. Further analysis revealed that adiponectin could induce apoptosis and arrest the cell cycle progression at G(0)-G(1) phase in MDA-MB-231 cells. Prolonged treatment with adiponectin in this cell line blocked serum-induced phosphorylation of Akt and glycogen synthase kinase-3beta (GSK-3beta), suppressed intracellular accumulation of beta-catenin and its nuclear activities, and consequently reduced expression of cyclin D1. Adiponectin-mediated suppression of cyclin D1 expression and attenuation of cell proliferation was abrogated by the GSK-3beta inhibitor lithium chloride. These results suggest that the inhibitory role of adiponectin on MDA-MB-231 cell growth might be attributed to its suppressive effects on the GSK-3beta/beta-catenin signaling pathway. Furthermore, our in vivo study showed that both supplementation of recombinant adiponectin and adenovirus-mediated overexpression of this adipokine substantially reduced the mammary tumorigenesis of MDA-MB-231 cells in female nude mice. Taken together, these data support the role of adiponectin as a negative regulator of breast cancer development and also suggest that adiponectin might represent a novel therapeutic target for this disease.
Similar articles
-
Adiponectin Suppresses Human Pancreatic Cancer Growth through Attenuating the β-Catenin Signaling Pathway.Int J Biol Sci. 2019 Jan 1;15(2):253-264. doi: 10.7150/ijbs.27420. eCollection 2019. Int J Biol Sci. 2019. PMID: 30745818 Free PMC article.
-
Embelin-Induced Apoptosis of Human Prostate Cancer Cells Is Mediated through Modulation of Akt and β-Catenin Signaling.PLoS One. 2015 Aug 7;10(8):e0134760. doi: 10.1371/journal.pone.0134760. eCollection 2015. PLoS One. 2015. PMID: 26252009 Free PMC article.
-
Fangchinoline inhibits cell proliferation via Akt/GSK-3beta/ cyclin D1 signaling and induces apoptosis in MDA-MB-231 breast cancer cells.Asian Pac J Cancer Prev. 2014;15(2):769-73. doi: 10.7314/apjcp.2014.15.2.769. Asian Pac J Cancer Prev. 2014. PMID: 24568493
-
GSK-3beta regulates cyclin D1 expression: a new target for chemotherapy.Cell Signal. 2008 Apr;20(4):581-9. doi: 10.1016/j.cellsig.2007.10.018. Epub 2007 Oct 23. Cell Signal. 2008. PMID: 18023328 Review.
-
Adiponectin as a negative regulator in obesity-related mammary carcinogenesis.Cell Res. 2007 Apr;17(4):280-2. doi: 10.1038/cr.2007.14. Cell Res. 2007. PMID: 17404599 Review. No abstract available.
Cited by
-
Update on Adipose Tissue and Cancer.Endocr Rev. 2023 Nov 9;44(6):961-974. doi: 10.1210/endrev/bnad015. Endocr Rev. 2023. PMID: 37260403 Free PMC article.
-
Unraveling the Role of Adiponectin Receptors in Obesity-Related Breast Cancer.Int J Mol Sci. 2023 May 17;24(10):8907. doi: 10.3390/ijms24108907. Int J Mol Sci. 2023. PMID: 37240258 Free PMC article. Review.
-
Targeting Breast Cancer Stem Cells.Int J Biol Sci. 2023 Jan 1;19(2):552-570. doi: 10.7150/ijbs.76187. eCollection 2023. Int J Biol Sci. 2023. PMID: 36632469 Free PMC article. Review.
-
Targeting Adiponectin in Breast Cancer.Biomedicines. 2022 Nov 17;10(11):2958. doi: 10.3390/biomedicines10112958. Biomedicines. 2022. PMID: 36428526 Free PMC article. Review.
-
Adiponectin Suppresses Metastasis of Nasopharyngeal Carcinoma through Blocking the Activation of NF-κB and STAT3 Signaling.Int J Mol Sci. 2022 Oct 22;23(21):12729. doi: 10.3390/ijms232112729. Int J Mol Sci. 2022. PMID: 36361525 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous